Search

everythinglearnresearchcommunity

for

Search:↓

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Folliculotropic mycosis fungoides can occur in children and is diagnosed with specific tests, but often stays in early stages with treatment.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Human hair follicles have a scent receptor that can influence hair growth.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Psoriasis skin changes are complex and might need several biopsies for a clear diagnosis.

Mice lacking fibromodulin have disrupted healing patterns, leading to abnormal skin repair and scarring.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

A man had both alopecia areata and lichen planus, which is uncommon.

Claudin-1 and Claudin-3 are crucial for keeping hair follicle structure and preventing a type of hair loss called telogen effluvium.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Erianin may effectively treat alopecia areata by targeting the immune system.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.